Stay updated on IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page was updated to a newer ClinicalTrials.gov interface revision (revision version increased from v3.5.2 to v3.5.3). This represents a platform/UI update rather than a change to the underlying clinical trial record information.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision history updated to include version 3.5.0 and remove version 3.4.3.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 was added to the history; the funding-lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a government funding notice banner and updated the page revision to v3.4.1, removing the previous v3.4.0 reference.SummaryDifference0.4%

Stay in the know with updates to IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page.